MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MicroTech Medical Hangzhou Co Ltd
PP&E Net
MicroTech Medical Hangzhou Co Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
PP&E Net
¥220.9m
|
CAGR 3-Years
31%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
PP&E Net
¥832.8m
|
CAGR 3-Years
38%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
PP&E Net
¥1.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
15%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
PP&E Net
¥11.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
PP&E Net
¥558.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
PP&E Net
¥4.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
MicroTech Medical Hangzhou Co Ltd
Glance View
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.
See Also
What is MicroTech Medical Hangzhou Co Ltd's PP&E Net?
PP&E Net
220.9m
CNY
Based on the financial report for Dec 31, 2025, MicroTech Medical Hangzhou Co Ltd's PP&E Net amounts to 220.9m CNY.
What is MicroTech Medical Hangzhou Co Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
24%
Over the last year, the PP&E Net growth was 5%. The average annual PP&E Net growth rates for MicroTech Medical Hangzhou Co Ltd have been 31% over the past three years , 24% over the past five years .
